Oxford Biodynamics (LON:OBD) announced its quarterly earnings results on Tuesday. The biotechnology company reported GBX (3) (($0.04)) EPS for the quarter, Digital Look Earnings reports.
OBD traded down GBX 2 ($0.03) during trading on Thursday, hitting GBX 101.50 ($1.34). The company’s stock had a trading volume of 13,489 shares, compared to its average volume of 67,675. The stock has a market cap of $93.95 million and a PE ratio of -44.13. Oxford Biodynamics has a twelve month low of GBX 75.11 ($0.99) and a twelve month high of GBX 214 ($2.82). The firm’s 50 day moving average price is GBX 117.26 and its 200-day moving average price is GBX 115.01.
Separately, Shore Capital restated a “house stock” rating on shares of Oxford Biodynamics in a research report on Friday, October 25th.
Oxford Biodynamics Company Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures.
Featured Story: What are popular green investing opportunities?
Receive News & Ratings for Oxford Biodynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biodynamics and related companies with MarketBeat.com's FREE daily email newsletter.